alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1

                            CERTIFICATION PURSUANT TO
                SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

I, Gad Tamari, certify that:

1. I have reviewed this annual report on Form 10-K of RADVision Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d- 15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

(b) [Paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986]

(c) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent function):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: March 15, 2004

 /s/ Gad Tamari*
---------------
Gad Tamari

Chief Executive Officer
* The originally executed copy of this Certification will be maintained at the
Company's offices and will be made available for inspection upon request.
Case 3:11-mj-02525-DEA     Document 36     Filed 06/09/14     Page 1 of 2 PageID: 82

Case 3:11-mj-02525-DEA     Document 36     Filed 06/09/14     Page 2 of 2 PageID: 83
#### UNITED STATES v. ELM SPRING FARM CO. et al.

No. 4525.

District Court, D. Massachusetts.

May 1, 1942.

*44See, also, 38 F.Supp. 508.

Edmund J. Brandon, U.S. Atty. and Joseph P. Rooney, Asst. U. S. Atty., both of Boston. Mass., for the United States.

G. K. Richardson and Wm. E. Bennett, of Richardson, Wolcott, Patten & Bennett, both of Boston, Mass., for Elm Spring Farm, Inc., Elm Spring Farm Co., Etta S. Giles & Francis Cummings.

David Greer of Boston, Mass., for Howard L. Chisholm.

SWEENEY, District Judge.

On September 20, 1940, the plaintiff filed a petition for attachment for contempt against five defendants. Service was not made on two of them, and the Government’s motion to dismiss the petition as to these two was allowed. The other defendants filed motions to dismiss, and, although briefs were filed in support of their motions, no action was taken on them by the court.

On April 7, 1942, the Government filed a motion to dismiss the petition without prejudice under Federal Rules of Civil Procedure, rule 41(a) (2), 28 U.S.C.A. following section 723c. The defendants object to the allowance of the Government’s motion to dismiss without prejudice, although their motions to dismiss did not include a prayer for dismissal with or with■out prejudice.

In a brief supporting the defendants’ motions to dismiss appears the suggestion that in the present practice a motion to dismiss takes the place of a demurrer. For the purposes of this case. I accept this statement as true. If the defendants’ motions had been allowed the Government would have been accorded the right to amend its petition within a reasonable time thereafter. No harm can accrue to the defendants by the allowance of the Government’s present motion. Although the basis of the Government’s present motion is newly discovered evidence of other contempts, it is reasonable to expect that this court would have allowed the original petition to be again amended so as to include them.

The defendants now insist that if the Government’s motion is allowed, it should be with prejudice. Since there has been no hearing on the merits, such a contention cannot prevail. It will be more orderly to include all of the violations in a new petition both as to parties and allegations, and have the matter once determined rather than have it determined piecemeal or under new amendments to the old petition. The Government’s motion to dismiss without prejudice is therefore allowed. Since the dismissal sought is for the purpose of consolidating the old allegations of contemptuous acts with others newly discovered, the plaintiff is ordered to include all of its known claims in one new petition.
EXHIBIT 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Annual  Report  of  Domark  International,  Inc.  (the
"Company") on Form 10-Q for the period ended November 30, 2012 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Andrew
Ritchie,  Principal  Financial Officer of the Company,  certify,  pursuant to 18
U.S.C.  section 1350, as adopted  pursuant to section 906 of the  Sarbanes-Oxley
Act of 2002, That to the best of my knowledge:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.

DOMARK INTERNATIONAL, INC.


By /s/ Andrew Ritchie
   ------------------------------------
   Andrew Ritchie
   Principal Financial Officer
   January 22, 2012
----

| 1. | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The information contained in                the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                  |   |                                     |   |
|-------------------------------------------------------|--------|------------------------------------------|--------|
| Date:                November 14,                2007 | By:    | /s/ Michael              McLaren    |   |
|                                                  |   | Michael              McLaren             |   |
|                                                  |   | Principal              Executive Officer |   |
|                                                  |   |                                     |   |
EXHIBIT 10.15


Fee Settlement Agreement
 
 Recitals
  AGREEMENT entered into this 20th day of August. 2013. by and between Seafarer Exploration Corp (the "Company"), and ClearTrust. LLC ("Transfer Agent").
  WHERHAS, the Transfer Agent has incurred various reimbursable expenses resulting directly from acting as transfer agent for the Company, and the Company is obligated to reimburse the Transfer Agent for said expenses.
  NOW, THEREFORE, the Company and Transfer Agent hereby agree to settle the amount owed to the Transfer Agent with shares of restricted stock. The parties hereto agree as fol lows:
  1.Legal Expenses Owed
  The transfer agent has incurred reimbursable expenses and invoiced the Company as detailed in the table below:
  Date of Invoice to C ompan
Invoice Number
Amount
Reason for Invoice6/5/13
2426
$978.00
Legal expenses related to "Eldred vs.Seafarer" case7/1/13
1533
$3.954.03
Legal expenses related to "Eldred vs.Seafarer" case8/8/13
2642
$798.74
Legal expenses related to "Eldred vs.Seafarer" caseTOTAL
S5,730.77
  2.Issuance of Stock
  TheCompany shall reimburse the Transfer Agent cashless with a non-refundable payment of 458,462 shares of restricted common stock of the Company. The Transfer Agent may sell the shares in the public marketplace in reliance on Rule 144 ornegotiate the sale of the shares in a privately negotiated transaction. Regardless the manner of sale, the Transfer Agent must apply all proceeds gained by the sale of the shares to the open invoices listed in the table above. Should the Transfer Agent realize less proceeds than the total due in the table above, the Transfer Agent may request up to 400.000 additional shares of stock or a cash payment to cover  the  difference  in  the  amount owed.
  5. Severability
  In the event that any one or more provisions herein shall for any reason he held to be invalid. illegal or unenforceable in any respect. such invalidity, illegality or unenforceability shall not affect any other provision hereof.
  1


6. Miscellaneous
  This Agreement (i) constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and shall supersede all prior understandings and agreements as to such subject matter: (ii) may be amended or modified only by a writing executed by the party against whom enforcement is sought: (iii) shall inure to the benefit of and be binding upon the respective heirs. administrators. personal representatives. successors and assigns of the parties hereto: and (iv) shall be governed by and construed in accordance with the laws of Florida.
  IN WITNESS WHEREOF. the parties hereto have executed this Fee Settlement Agreement as of the date and year first above written.
  CLEARTIRUST, LLC:
   
    SEAFARER EXPLORATION CORP.
  
 
 Kyle Kenndy, Director
    2
907 A.2d 1010

#### STATE OF NEW JERSEY, PLAINTIFF-RESPONDENT, v. JEROME YOUNG, DEFENDANT-PETITIONER.

September 12, 2006.

ORDERED that the petition for certification is granted limited to the issue of defendant’s sentence to a discretionary persistent-offender extended term under *N.J.S.A.*2C:44-3a, and the matter is summarily remanded to the trial court for resentencing in light *350of the Court’s decision in *State v. Pierce,*188 *N.J.*155, 902 A.2d 1195 (2006).
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 1 of 7 PageID: 827
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 2 of 7 PageID: 828
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 3 of 7 PageID: 829
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 4 of 7 PageID: 830
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 5 of 7 PageID: 831
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 6 of 7 PageID: 832
Case 3:11-cv-02511-FLW-DEA Document 56 Filed 07/16/12 Page 7 of 7 PageID: 833
Case 3:11-cv-02276-MLC-DEA   Document 14   Filed 05/26/11   Page 1 of 2 PageID: 136

Case 3:11-cv-02276-MLC-DEA   Document 14   Filed 05/26/11   Page 2 of 2 PageID: 137
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Balance
Sheet, Statement of Operations, Statements of Cash Flows and Notes thereto
incorporated in Part I, Item 1. of this Form 10KSB and is qualified in its
entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          28,145
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                28,145
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  28,145
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        47,400
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    28,145
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                    2,855
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (2,855)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,855)
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
EXHIBIT 99.1


                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In  connection  with the  Annual  Report of  Energy  Producers,  Inc.  (the
"Company") on Form 10-KSB for the period ending December 31, 2002, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I, Mel
Herzog,  Chairman and CEO of the  Company,  certify,  pursuant to 18 U.S.C.  ss.
1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.



/s/ Mel Herzog
-------------------
Mel Herzog
Chief Executive Officer
Date:  April 14, 2003
Exhibit 10.2

 

February 26, 2013

 

Board of Directors of Optimer Pharmaceuticals, Inc.,

101 Hudson Street, Suite 3501,

Jersey City, NJ  07302.

 

Members of the Board,

 

I defer to your decision to appoint Meredith Schaum as General Counsel and, subject to your acceptance, resign as General Counsel, Chief Compliance Officer, Senior Vice President and Secretary of Optimer Pharmaceuticals, Inc.

 

This letter confirms the understanding that my resignation will be treated for purposes of my employment arrangements with Optimer as a termination without cause and your agreement that you will pay amounts due me under the severance plan in a lump sum.  In addition, I recognize that events occurring during my tenure at Optimer are under heightened scrutiny.  I therefore confirm that I will repay any amounts and benefits I receive as a result of such treatment of my resignation in the event that it is finally determined by a court that I engaged in any act for which I would not be entitled to indemnification under Section 8.1 of Optimer’s by-laws.

 

	
 
    	
Very truly yours,
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
/s/ Kurt Hartman
    
	
 
    	
Kurt Hartman
    


 

Accepted and Agreed:

 

 

Optimer Pharmaceuticals, Inc.

 

 

	
By:
    	
/s/ Anthony E.   Altig
    	
 
    
	
Anthony E. Altig
    	
 
    
	
Chairman, Compensation and Governance/
    	
 
    
	
Nominating Committee
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

MOUNTAIN CREEK PROPERTIES, LP,

Petitioner

v.

HONORABLE SUSAN DAY, MAGISTERIAL

DISTRICT JUDGE,

Respondent :

:

:

:

:

:

:

:

:

:

:

: No. 181 MM 2020

ORDER

PER CURIAM

AND NOW , this 9th day of March , 2021, the “Petition for Issuance of Writ of

Mandamus” is DENIED. The Prothonotary is DIRECTED to strike the name of the jurist

from the caption.
Case 2:10-cv-04017-SDW -MCA Document 70 Filed 02/15/11 Page 1 of 1 PageID: 1441
Exhibit
32.1


CERTIFICATION





In
connection with the quarterly report on Form 10-Q of CYBRA Corporation. (the
“Company”) for the period ended September 30, 2008 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Harold Brand,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350,
that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.








Date: May
13,
2009                                                              /s/Harold
Brand


Harold Brand


Chief Executive Officer
Exhibit 32.1




CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,




AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In connection with the Quarterly Report of Helix Wind, Corp. (the "Company") on Form 10-Q for the period ending September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:




(a)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(b)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




Date: November 5, 2010
/s/ Scott WeinbrandtScott Weinbrandt, Chief Executive Officer(Principal Executive Officer)
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03
- 17
- 00066
- CR

Roger Alexander Conant, Appellant

v. The State of Texas, Appellee

FROM THE COUNTY COUR T AT LAW NO. 3 OF TR AVIS COUNTY NO. C
- 1
- CR
- 14
- 213580 , THE HONORABLE JOHN LIPSCOMBE, JUDGE P RESIDING

O R D E R

PER CURIAM Appellant’s brief on appeal was originally due July 24, 2017. On counsel’s motions, the time for filing was extended to December 20, 2017. Appellant’s counsel has now filed a fourth motion, requesting that the Court ext end the time for filing appellant’s brief. We
grant the motion for extension of time and order appellant to file a brief no later than February
20 , 2018 . No further extension of time will be granted and failure to comply with this order will
result in th e referral of this case to the trial court for a hearing under Rule 38.8(b) of the Texas Rules of Appellate Procedure.
It is ordered on February 6 , 2018.

Before Justices Puryear, Pemberton, and Bourland
Do Not Publish
EX-10.20



 Exhibit 10.20 
 Non-Employee Directors’ Compensation for 2013 
 At its regularly scheduled meeting on
December 10, 2012, the Board of Directors of Aqua America, Inc., upon the recommendation of its Executive Compensation Committee, approved the following directors’ compensation for 2013 for the non-employee directors of Aqua America, Inc.:
(1) an annual cash retainer of $40,000; (2) an annual cash retainer for the Chair of the Executive Compensation Committee of $7,500; (3) an annual cash retainer for the Chair of the Audit Committee of $10,000; (4) an annual cash
retainer for the Chair of the Corporate Governance Committee, who also serves as the lead independent directors, of $10,000; (5) a meeting fee of $1,500 for each meeting of the Board of Directors; (5) a meeting fee of $1,500 per meeting
for meetings of the Board Committees; and (6) an annual stock grant to directors of $50,000, rounded to the nearest 100 shares payable on the first of the month following the Annual Meeting of Shareholders. All directors are reimbursed for
reasonable expenses incurred in connection with attendance at Board or Committee meetings.
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 1 of 20 PageID: 1
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 2 of 20 PageID: 2
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 3 of 20 PageID: 3
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 4 of 20 PageID: 4
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 5 of 20 PageID: 5
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 6 of 20 PageID: 6
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 7 of 20 PageID: 7
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 8 of 20 PageID: 8
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 9 of 20 PageID: 9
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 10 of 20 PageID: 10
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 11 of 20 PageID: 11
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 12 of 20 PageID: 12
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 13 of 20 PageID: 13
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 14 of 20 PageID: 14
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 15 of 20 PageID: 15
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 16 of 20 PageID: 16
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 17 of 20 PageID: 17
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 18 of 20 PageID: 18
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 19 of 20 PageID: 19
Case 2:11-cv-02539-WJM-MF Document 1 Filed 05/04/11 Page 20 of 20 PageID: 20
Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 1 of 12 PageID: 34

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 2 of 12 PageID: 35

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 3 of 12 PageID: 36

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 4 of 12 PageID: 37

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 5 of 12 PageID: 38

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 6 of 12 PageID: 39

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 7 of 12 PageID: 40

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 8 of 12 PageID: 41

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 9 of 12 PageID: 42

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 10 of 12 PageID: 43

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 11 of 12 PageID: 44

Case 2:11-cv-02341-SDW-MCA   Document 5   Filed 06/23/11   Page 12 of 12 PageID: 45